02/15/2021

The Medicare Access for Patients Rx (MAPRx) Coalition is writing in opposition to recent changes, announced on January 19, 2021 under the prior administration, allowing plans to severely limit Part D formularies in the CMS Center for Medicare and Medicaid Innovation (CMMI) Part D Payment Modernization (PDM) Model for plan year 2022. We urge you to rescind these formulary changes, which circumvent current law and allow plans flexibility with the six protected classes and enable plans to significantly restrict drug coverage to one drug per class for all drugs covered under Part D. These changes undermine long-standing beneficiary protections and could, not only limit the ability of beneficiaries to access needed medications, but also jeopardize the health – and in some instances, life - of those with serious and chronic conditions.